It's good to see drug developers addressing the issue of comparator drug sourcing and working hard to change the way they manage comparator products in clinical trials. Getting comparator sourcing right is crucial because there is increasing pressure from patients and payers to develop drugs that are substantially better than existing treatments.
2 parts